CHGCY Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. (CHGCY) is expected to report earnings on October 23, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -4.5% since its last earnings release on July 24, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Chugai Pharmaceutical Co., Ltd.
CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.
Sector
Healthcare
Industry
Drug Manufacturers/Other